Experts say the increasing public health threat of antimicrobial resistance (AMR) is already putting vulnerable patients at risk, but Congress could step in to help. Testifying on July 11 before members of the Senate Health, Education, Labor, and Pensions Committee, Melinta Therapeutics President and CEO Christine Ann Miller noted that the issue was not far…